EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Plozasiran: First Approval

Yahiya Y Syed

Drugs · 2026-05 · 86 (5) · 753-758

DOI: 10.1007/s40265-026-02293-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drugs, online erschienen am 06.03.2026. Verfasst von Yahiya Y Syed. Beteiligte Einrichtung: Springer Nature, Mairangi Bay, Private Bag 65901, Auckland, 0754, New Zealand. dru@adis.com. Hauptthemen laut MEDLINE: Hyperlipoproteinemia Type I, Apolipoprotein C-III, RNA, Small Interfering. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Plozasiran (Redemplo®) is a first-in-class GalNAc-conjugated small interfering RNA (siRNA) designed to reduce hepatic apolipoprotein C-III (ApoC3) production. It is being developed by Arrowhead Pharmaceuticals for the treatment of familial chylomicronemia syndrome (FCS), severe hypertriglyceridaemia and mixed hyperlipidaemia. Plozasiran degrades ApoC3 mRNA via RNA interference, reducing hepatic and serum ApoC3 levels and thereby enhancing catabolism and clearance of serum triglycerides. It received its first approval in the USA on 18 November 2025 as an adjunct to diet to reduce triglycerides in adults with FCS. This article summarizes the key milestones in the clinical development of plozasiran leading to its first approval for FCS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperlipoproteinemia Type IApolipoprotein C-IIIRNA, Small InterferingHumansDrug ApprovalTriglyceridesAnimalsHypertriglyceridemiaUnited States

Substanzen

Apolipoprotein C-IIIRNA, Small InterferingTriglyceridesplozasiran

Autor:innen und Institutionen

  • Springer Nature, Mairangi Bay, Private Bag 65901, Auckland, 0754, New Zealand. dru@adis.com.

Zitieren

APA

Syed, Y. Y. (2026). Plozasiran: First Approval. Drugs, 86(5), 753-758. https://doi.org/10.1007/s40265-026-02293-2

Vancouver

Syed YY. Plozasiran: First Approval. Drugs. 2026;86(5):753-758. doi:10.1007/s40265-026-02293-2

BibTeX
@article{Syed2026,
  author = {Syed, Yahiya Y},
  title = {Plozasiran: First Approval},
  journal = {Drugs},
  year = {2026},
  volume = {86},
  number = {5},
  pages = {753--758},
  doi = {10.1007/s40265-026-02293-2}
}
Kostenlos starten →